Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial - Concepedia

Concepedia

Publication | Closed Access

Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial

71

Citations

29

References

2011

Year

Yuzuru Kanakura, Kazuma Ohyashiki, Tsutomu Shichishima, Shinichiro Okamoto, Kiyoshi Ando, Haruhiko Ninomiya, Tatsuya Kawaguchi, Shinji Nakao, Hideki Nakakuma, J Nishimura,

International Journal of Hematology

MedicineHematologyParoxysmal Nocturnal HemoglobinuriaAegis Clinical TrialPharmacologyJapanese Patients

References

	Year	Citations

Page 1